Research Article
Improving Diabetes Care: A Fijian Diabetes Service Improvement Study
Table 3
Description of comorbidities present in the study population. Type 2 diabetes related comorbidities in the study population (
).
| Comorbidities | |
| Macrovascular diseases | 36% (42) | IHD | 36% (41) | Stroke | 4% (5) | PVD | 1% (1) | Concurrent macrovascular diseases | | IHD + stroke | 4% (4) | IHD + PVD | 1% (1) |
| Microvascular diseases | 33% (37) | CKD | 27% (31) | Retinopathy | 1% (1) | Peripheral neuropathy | 3% (3) | Amputation | 3% (3) | Concurrent microvascular diseases | | Retinopathy + peripheral neuropathy | 1% (1) |
| Metabolic syndrome (hypertension + dyslipidemia) | 5% (6) | Hypertension only | 27% (30) | Hypertension + other disease states | 77% (87) |
| No co-morbidities | 4% (5) |
|
|
Key: IHD: ischemic heart disease; PVD: peripheral vascular disease; CKD: chronic kidney disease.
|